PPARG and neoplasm: It was also demonstrated that DC treatment at the dose of 3.0 mg/kg could significantly suppress tumor growth and show no apparent toxicity in the xenograft nude mouse model in vivo. In addition, our study also supports DC as a unique PPARγ agonist for antitumor lead compounds.